Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and scalaradial

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with scalaradial in 3 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(scalaradial)
Trials
(scalaradial)
Recent Studies (post-2010) (scalaradial)
9,1561875523105

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)scalaradial (IC50)
Phosphatidylcholine 2-acylhydrolase Apis mellifera (honey bee)0.07
Transient receptor potential cation channel subfamily M member 2Rattus norvegicus (Norway rat)0.33
Transient receptor potential cation channel subfamily M member 2Homo sapiens (human)0.21
Phospholipase A2Apis mellifera (honey bee)0.07
Transient receptor potential cation channel subfamily M member 7Mus musculus (house mouse)0.76

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bolognese, B; Griswold, DE; Jacobs, R; Marshall, LA; Roshak, A; Sung, CM; Webb, EF; Winkler, JD1
Bauer, J; Carlson, RP; Glaser, KB; Hartman, DA; Lock, YW; Sung, ML; Walter, T1
Bolognese, BJ; Marshall, LA; Roshak, AK; Sung, CM; Winkler, JD1

Other Studies

3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and scalaradial

ArticleYear
Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 268, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Homosteroids; Humans; Leukotrienes; Male; Mice; Mice, Inbred BALB C; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Sesterterpenes; Terpenes; Tetradecanoylphorbol Acetate

1994
Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2.
    Skin pharmacology : the official journal of the Skin Pharmacology Society, 1995, Volume: 8, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Eicosanoids; Ellagic Acid; Homosteroids; Humans; Inflammation; Macrophages; Male; Mice; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Sesterterpenes; Skin; Synovial Fluid; Terpenes

1995
Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.
    Biochimica et biophysica acta, 1997, Jun-02, Volume: 1346, Issue:2

    Topics: Acyltransferases; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Benzenesulfonates; Calcimycin; Enzyme Inhibitors; Homosteroids; Humans; Monocytes; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Recombinant Proteins; Sesterterpenes; Sulfonamides; Terpenes; Urea

1997